Phagenesis

Phagenesis is a MedTech company developing a neurostimulation system (Phagenyx) to treat swallowing dysfunction (dysphagia). The system targets and restores neurological components of swallowing, addressing a significant unmet need for patients with brain injuries or those who have undergone prolonged mechanical ventilation. This innovative therapy offers improved patient recovery and reduced healthcare costs.

Buy Funded Startups lists

Funding Round: Series D

Funding Amount: $42M

Date: 04-Mar-2024

Investors: EQT Life Sciences, Sectoral, British Patient Capital, Northern Gritstone, Aphelion/Cardeation Capital

Markets: MedTech, Neurostimulation, Healthtech, Medical Device

HQ: Manchester, England, United Kingdom

Founded: 2007

Website: https://www.phagenesis.com/

LinkedIn: https://www.linkedin.com/company/phagenesis-ltd

Twitter: http://twitter.com/phagenesis

Instagram: